Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.84 | N/A |
| PEG Ratio (TTM) | -0.57 | N/A |
| P/S Ratio (TTM) | 0.43 | N/A |
| P/B Ratio (TTM) | 0.61 | N/A |
| P/FCF Ratio (TTM) | -5.32 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.67 | N/A |
| Price to 5YR AVG FCF Ratio | 10.53 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.91% | N/A |
| ROE (TTM) | 3.48% | N/A |
| Net Profit Margin (TTM) | 2.41% | N/A |
| ROIC 5YR AVG | 18.99% | N/A |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 39.37% | 49.70% | 10.69% |
| Revenue | -3.46% | 24.90% | 12.86% |
| Net Income | 39.76% | 73.08% | 23.03% |
| Cash Flow | 397.30% | 918.90% | 540.46% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.67 | N/A |
| Quick Ratio (TTM) | 1.08 | N/A |
| D/E Ratio (TTM) | 0.37 | N/A |
| Interest Coverage (TTM) | 10.72 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.96 | N/A |
| LTL to 5YR AVG FCF | 6.03 | N/A |
| Shares Outstanding Growth 5YR AVG | 6.13% | N/A |